Quick Answer
CG Oncology, Inc. reported Shares Outstanding of 80.69 million shares for fiscal year 2025.
CG Oncology, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 80.69M | +6.0% |
| 2024 | 76.15M | +1358.3% |
| 2023 | 5.22M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 78.28M | +15.9% | +2.7% |
| June 30, 2025 | 76.23M | +14.4% | +0.0% |
| March 31, 2025 | 76.22M | +14.4% | +0.1% |
| December 31, 2024 | 76.15M | +1358.3% | +12.8% |
| September 30, 2024 | 67.54M | — | +1.3% |
| June 30, 2024 | 66.66M | — | +0.0% |
| March 31, 2024 | 66.64M | — | +1176.0% |
| December 31, 2023 | 5.22M | — | — |
- CG Oncology, Inc. showed an increase of +6.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, CG Oncology, Inc.’s shares outstanding has grown by 1445.1% (from 5.22 million shares to 80.69 million shares).
- The most recent figure is from CG Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: